Mehmet Fatih Yılmaz

Dr. Mehmet Fatih Yılmaz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Birth Defects Research
Verified
Journal Article
Closed access
PDF file
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
MTMahmut Sami Tutar
Mahmut Sami Tutar
DADerya Arslan
Derya Arslan
AÇAyhan Çeri
Ayhan Çeri

25 May 2021 in The Journal of Pediatric Research
Verified
Journal Article
Closed access
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
NENuriye Emiroğlu
Nuriye Emiroğlu
NGNazlı Dilay Gültekin
Nazlı Dilay Gültekin
MYMehmet Yücel
Mehmet Yücel
RKRamazan Keçeci
Ramazan Keçeci
HAHüseyin Altunhan
Hüseyin Altunhan

1 June 2017 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
SYSevil Arı Yuca
Sevil Arı Yuca
HVHüsamettin Vatansev
Hüsamettin Vatansev
ECEmine Ayça Cimbek
Emine Ayça Cimbek
YŞYaşar Şen
Yaşar Şen
AYAlaaddin Yorulmaz
Alaaddin Yorulmaz
Objective: This study aimed to measure the serum levels of heart-type fatty acid binding protein (H-FABP) in patients presenting with diabetic ketoacidosis (DKA) and diabetic ketosis (DK) and to determine its role in identifying early-period cardiac ischemia. Methods: This prospective study included 35 patients diagnosed with DKA, 20 patients diagnosed with DK, and 20 control subjects. H-FABP, creatine kinase-MB (CK-MB), and troponin I levels were investigated at presentation in patients with DKA and DK and in the control group. H-FABP values were measured again after acidosis correction in the DKA patients. Results: No statistically significant differences were found with respect to troponin I and CK-MB within the groups. The H-FABP values of DKA patients at presentation were found to be significantly higher than those of DK patients and the control group (p = 0.015). The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p = 0.0001). Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.

5 July 2018 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
PDF file
NGN. Dilay Gültekin
N. Dilay Gültekin
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
HAH. Altunhan
H. Altunhan
SFS. Findik
S. Findik
HTH. Tokgöz
H. Tokgöz
ÜÇÜmran Çalişkan
Ümran Çalişkan
Kasabach-Merritt syndrome is a rare life-threatening clinical presentation in neonatal period. it is characterized by giant hemangioma and serious thrombocytopenia. The diagnostic criteria include: 1) hemangiomas on skin, 2) thrombocytopenia or coagu

9 June 2021 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
AÇAyhan Çeri
Ayhan Çeri

30 December 2022 in Abant Medical Journal
Verified
Journal Article
Open access
PDF file
MYMehmet Fatih Yılmaz
Mehmet Fatih Yılmaz
BKBuket Kara
Buket Kara
KEKübra Ertan
Kübra Ertan
Introduction: Indirect hyperbilirubinemia is an important problem in newborns and phototherapy has an important role in treatment. The aim of this study is to evaluate the effects of phototherapy on hematological parameters in newborns with indirect hyperbilirubinemia. Method: In the last three months, 60 newborns (term = 30 and preterm = 30) diagnosed and treated for indirect hyperbilirubinemia were included in this study. Results: Twelve of the neonatal terms (40%) had either Rh incompatibility (n = 3) or ABO incompatibility (n = 9), 10 of the preterm newborns (33%) had either Rh incompatibility (n = 3) or ABO incompatibility (n = 7). The median durations of phototherapy of term and preterm newborns were 24 (range, 6-40) and 11 hours (range, 4-36), respectively. After phototherapy, it was found that the counts of WBC and RBC, Hb, MCV and RDW values of term newborns decreased statistically (p values were .0187, .0007, 0001, .0036 and